These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 27230923

  • 1. Optimal Acquisition Time Window and Simplified Quantification of Dopamine Transporter Availability Using 18F-FE-PE2I in Healthy Controls and Parkinson Disease Patients.
    Sonni I, Fazio P, Schain M, Halldin C, Svenningsson P, Farde L, Varrone A.
    J Nucl Med; 2016 Oct; 57(10):1529-1534. PubMed ID: 27230923
    [Abstract] [Full Text] [Related]

  • 2. Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4'-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease.
    Fazio P, Svenningsson P, Forsberg A, Jönsson EG, Amini N, Nakao R, Nag S, Halldin C, Farde L, Varrone A.
    J Nucl Med; 2015 May; 56(5):714-20. PubMed ID: 25791993
    [Abstract] [Full Text] [Related]

  • 3. Quantification and discriminative power of 18F-FE-PE2I PET in patients with Parkinson's disease.
    Delva A, Van Weehaeghe D, van Aalst J, Ceccarini J, Koole M, Baete K, Nuyts J, Vandenberghe W, Van Laere K.
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1913-1926. PubMed ID: 31776633
    [Abstract] [Full Text] [Related]

  • 4. PET imaging of dopamine transporters with [(18)F]FE-PE2I: Effects of anti-Parkinsonian drugs.
    Bang JI, Jung IS, Song YS, Park HS, Moon BS, Lee BC, Kim SE.
    Nucl Med Biol; 2016 Feb; 43(2):158-64. PubMed ID: 26872440
    [Abstract] [Full Text] [Related]

  • 5. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L, Jonasson M, Danfors T, Nyholm D, Askmark H, Lubberink M, Sörensen J.
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Simplified quantification of [18F]FE-PE2I PET in Parkinson's disease: Discriminative power, test-retest reliability and longitudinal validity during early peak and late pseudo-equilibrium.
    Brumberg J, Kerstens V, Cselényi Z, Svenningsson P, Sundgren M, Fazio P, Varrone A.
    J Cereb Blood Flow Metab; 2021 Jun; 41(6):1291-1300. PubMed ID: 32955955
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reproducibility of PET measurement for presynaptic dopaminergic functions using L-[β-(11)C]DOPA and [(18)F]FE-PE2I in humans.
    Suzuki M, Ito H, Kodaka F, Takano H, Kimura Y, Fujiwara H, Sasaki T, Takahata K, Nogami T, Nagashima T, Nengaki N, Kawamura K, Zhang MR, Varrone A, Halldin C, Okubo Y, Suhara T.
    Nucl Med Commun; 2014 Mar; 35(3):231-7. PubMed ID: 24468851
    [Abstract] [Full Text] [Related]

  • 11. Age-related decline in dopamine transporter in human brain using PET with a new radioligand [¹⁸F]FE-PE2I.
    Shingai Y, Tateno A, Arakawa R, Sakayori T, Kim W, Suzuki H, Okubo Y.
    Ann Nucl Med; 2014 Apr; 28(3):220-6. PubMed ID: 24385293
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nigrostriatal dopamine transporter availability in early Parkinson's disease.
    Fazio P, Svenningsson P, Cselényi Z, Halldin C, Farde L, Varrone A.
    Mov Disord; 2018 Apr; 33(4):592-599. PubMed ID: 29436751
    [Abstract] [Full Text] [Related]

  • 20. Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT.
    Davis MR, Votaw JR, Bremner JD, Byas-Smith MG, Faber TL, Voll RJ, Hoffman JM, Grafton ST, Kilts CD, Goodman MM.
    J Nucl Med; 2003 Jun; 44(6):855-61. PubMed ID: 12791810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.